Browsing NTNU Open by Author "Berge, Viktor"
Now showing items 1-3 of 3
-
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
Møller, Christina Tanem; Støer, Nathalie Charlotte; Blindheim, Augun; Berge, Viktor; Tafjord, Gunnar; Fosså, Sophie Dorothea; Kulle, Bettina (Peer reviewed; Journal article, 2022)Background Neoadjuvant chemotherapy (NAC) before radical cystectomy is associated with pathological downstaging (DS) and improved overall survival (OS) in patients with muscle-invasive bladder cancer (MIBC). Population-based ... -
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Braadland, Peder; Giskeødegård, Guro F.; Sandsmark, Elise; Bertilsson, Helena; Euceda, Leslie R.; Hansen, Ailin Falkmo; Guldvik, Ingrid Jenny; Selnæs, Kirsten Margrete; Grytli, Helene Hartvedt; Katz, Betina; Svindland, Aud; Bathen, Tone Frost; Eri, Lars Magne; Nygård, Ståle; Berge, Viktor; Tasken, Kristin Austlid; Tessem, May-Britt (Journal article; Peer reviewed, 2017)Background: Robust biomarkers that identify prostate cancer patients with high risk of recurrence will improve personalised cancer care. In this study, we investigated whether tissue metabolites detectable by high-resolution ... -
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Møller, Christina Tanem; Tafjord, Gunnar; Blindheim, Augun Jodis; Berge, Viktor; Fosså, Sophie Dorothea; Kulle, Bettina (Peer reviewed; Journal article, 2023)Before immunotherapy became part of the management of metastatic bladder cancer (mBC), systemic anti-cancer treatment comprised primarily of platinum-based chemotherapy. The objective of this study was to describe the ...